人乳头瘤病毒分型与Cervista检测在宫颈内皮病变中的诊断价值

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (0 KB) HTML (35 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To compare the diagnostic value of two methods of human papillomavirus(HPV)typing and Cervista detection in cervical intraepithelial neoplasia(CIN).Methods A total of 106 women with CIN1 and 210 women with CIN2+diagnosed by new baishi liquid-based cytology(TCT)and confirmed by cervical biopsy in our hospital from January 2017 to December 2018 were enrolled in this study.All participants underwent HPV typing and Cervista testing simultaneously.Then the diagnostic effect of the two tests was compared.Results The overall coincidence rate of the two HPV testing methods was 87.34%(276/316),and the KIvalue was 0.6377.The positive rate of HPV typing in CIN1 group was 51.88%,which was higher than that of Cervista testing(33.96%),the difference was statistically significant(P＜0.05),but there was no significant difference between the twomethods in the CIN2+group(P＞0.05).Conclusion The two methods are in good consistency and have equivalent diagnostic value in cervical cancer screening.HPV typing test has a higher positive rate in CIN1.

Key words： Cervical intraepithelial neoplasia Human papillomavirus Reverse dot blot Typing Cervista test

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	FAN Ju-hua
	QIN Yan
	SONG Chun-lin

Cite this article:

FAN Ju-hua,QIN Yan,SONG Chun-lin. Diagnostic value of human papillomavirus typing and Cervista detection in cervical intraepithelial neoplasia[J]. 中国当代医药, 2020, 27(9): 135-137.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I9/135

[1]	潘敏，邓再兴，桂启芳.液基细胞学联合高危型人乳头状瘤病毒-DNA检测在早期宫颈癌及癌前病变诊断中的临床价值[J].中国卫生检验杂志，2017，27（15）：2208-2210.
[2]	陈淑芬，峗淑莉，宋春林，等.佛山地区8985例HPV感染亚型分析[J].热带医学杂志，2015，15（3）：325-327.
[3]	姚军，李曼，钟萍，等.HPV亚型感染的地域分布与宫颈病变的关系[J].实用妇产科杂志，2011，27（1）：34-38.
[4]	Schiffman M，Solomon D.Clinical practice.Cervical-cancer screening with human papillomavirus and cytologic cotesting[J].N Engl JMed，2013，369（24）：2324-2331.
[5]	Li N，Franceschi S，Howell-Jones R，et al.Human papillomavirus type distribution in 30 848 invasive cervical cancers worldwide：Variation by geographical region，histological type and year of publication[J].Int JCancer，2011，128（4）：927-935.
[6]	李静然，张志军，王禹，等.阴道自取样HPV宫颈癌筛查联合宫颈细胞学p16-（INK4a）蛋白检测在精准筛查中的应用[J].中国妇产科临床杂志，2019，20（4）：321-325.
[7]	Arbyn M，Verdoodt F，Snijders PJ，et al.Accuracy of human papillomavirus testing on self-collected versus clinician collected samples：ameta-analysis[J].Lancet Oncol，2014，15（2）：172-183.
[8]	Liu Y，Zhang L，Zhao G，et al.The clinical research of Thinprep Cytology Test（TCT）combined with HPV-DNA detection in screening cervical cancer[J].Cell Mol Biol（Noisyle-grand），2017，63（2）：92-95.
[9]	董滨华，孙蓬明，毛晓丹，等.两种不同人乳头瘤病毒检测方法对子宫颈上皮内病变筛查价值的比较[J].中国妇产科临床杂志，2016，17（6）：494-497.
[11]	周成，郭晓玲，刘正平，等.佛山地区15867例女性HPV基因亚型分析[J].热带医学杂志，2017，17（3）：93-95.
[12]	莫菊玲，冯敏清，郑玉华，等.CervistaHPV检测在宫颈癌和宫颈上皮内瘤样病变中的诊断价值[J].国际检验医学杂志，2017，38（22）：3179-3181.
[10]	Berkhof J，Meijer C J.Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer[J].N Engl JMed，2007，357（6）：642-643.
[13]	程细云，余瑛，王冬梅.HC2与TCT检测在宫颈癌及癌前病变中的诊断价值[J].中国当代医药，2017，24（8）：66-68.
[14]	张朝清，刘丽，吴定滨，等.TCT联合HPV检查在宫颈癌患者筛查和诊断中的意义[J].中国当代医药，2018，25（6）：99-101.
[15]	吴志东，吴振勇，黄彩凤，等.TCT、HPV-DNA分型联合阴道镜检查在宫颈病变筛查中的应用价值[J].中国当代医药，2019，26（6）：133-136.
[16]	Alameda F，Garrote L，Mojal S，et al.Cervista HPV HR test for cervical cancer screening：a comparative study in the Catalonian population[J].Arch Pathol Lab Med，2015，139（2）：241-244.
[17]	Boers A，Slagter-Menkema L，van Hemel BM，et al.Comparing the Cervista HPV HR testand Hybrid Capture 2 assay in a Dutch screening population：improved specificity of the Cervista HPV HR test by changing the cut-off[J].PLoSOne，2017，9（7）：e101930.
[18]	董滨华，孙蓬明，毛晓丹，等.两种不同人乳头瘤病毒检测方法对子宫颈上皮内病变筛查价值的比较[J].中国妇产科临床杂志，2016，17（6）：494-497.